The report focuses on the Lamea Oncology/Anti-Cancer Drugs market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Lamea Oncology/Anti-Cancer Drugs market.
Major Players in the Lamea Oncology/Anti-Cancer Drugs market are:
EIMC United Pharmaceuticals
AbbVie
AstraZeneca
Sanofi
GlaxoSmithKline
Roche Diagnostics
Merck & Co.
Actavis plc.
Amgen
Novartis
On the basis of types, the Lamea Oncology/Anti-Cancer Drugs market is primarily split into:
Oral Therapy
Injectable Therapy
On the basis of applications, the market covers:
Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Others
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
Global Lamea Oncology/Anti-Cancer Drugs Market Research Report 2022 - Market Size, Current Insights and Development Trends
Table of Content
1 Lamea Oncology/Anti-Cancer Drugs Market Overview
1.1 Product Overview and Scope of Lamea Oncology/Anti-Cancer Drugs Market
1.2 Lamea Oncology/Anti-Cancer Drugs Market Segment by Type
1.2.1 Global Lamea Oncology/Anti-Cancer Drugs Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global Lamea Oncology/Anti-Cancer Drugs Market Segment by Application
1.3.1 Lamea Oncology/Anti-Cancer Drugs Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global Lamea Oncology/Anti-Cancer Drugs Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of Lamea Oncology/Anti-Cancer Drugs (2017-2029)
1.5.1 Global Lamea Oncology/Anti-Cancer Drugs Market Revenue Status and Outlook (2017-2029)
1.5.2 Global Lamea Oncology/Anti-Cancer Drugs Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the Lamea Oncology/Anti-Cancer Drugs Industry
1.7 Impact of Carbon Neutrality on the Lamea Oncology/Anti-Cancer Drugs Industry
2 Lamea Oncology/Anti-Cancer Drugs Market Upstream and Downstream Analysis
2.1 Lamea Oncology/Anti-Cancer Drugs Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of Lamea Oncology/Anti-Cancer Drugs Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream
3 Players Profiles
3.1 EIMC United Pharmaceuticals
3.1.1 EIMC United Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 Lamea Oncology/Anti-Cancer Drugs Market Performance (2017-2022)
3.1.4 Business Overview
3.2 AbbVie
3.2.1 AbbVie Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 Lamea Oncology/Anti-Cancer Drugs Market Performance (2017-2022)
3.2.4 Business Overview
3.3 AstraZeneca
3.3.1 AstraZeneca Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 Lamea Oncology/Anti-Cancer Drugs Market Performance (2017-2022)
3.3.4 Business Overview
3.4 Sanofi
3.4.1 Sanofi Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 Lamea Oncology/Anti-Cancer Drugs Market Performance (2017-2022)
3.4.4 Business Overview
3.5 GlaxoSmithKline
3.5.1 GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 Lamea Oncology/Anti-Cancer Drugs Market Performance (2017-2022)
3.5.4 Business Overview
3.6 Roche Diagnostics
3.6.1 Roche Diagnostics Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 Lamea Oncology/Anti-Cancer Drugs Market Performance (2017-2022)
3.6.4 Business Overview
3.7 Merck & Co.
3.7.1 Merck & Co. Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 Lamea Oncology/Anti-Cancer Drugs Market Performance (2017-2022)
3.7.4 Business Overview
3.8 Actavis plc.
3.8.1 Actavis plc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Product Profiles, Application and Specification
3.8.3 Lamea Oncology/Anti-Cancer Drugs Market Performance (2017-2022)
3.8.4 Business Overview
3.9 Amgen
3.9.1 Amgen Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Product Profiles, Application and Specification
3.9.3 Lamea Oncology/Anti-Cancer Drugs Market Performance (2017-2022)
3.9.4 Business Overview
3.10 Novartis
3.10.1 Novartis Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Product Profiles, Application and Specification
3.10.3 Lamea Oncology/Anti-Cancer Drugs Market Performance (2017-2022)
3.10.4 Business Overview
4 Global Lamea Oncology/Anti-Cancer Drugs Market Landscape by Player
4.1 Global Lamea Oncology/Anti-Cancer Drugs Sales and Share by Player (2017-2022)
4.2 Global Lamea Oncology/Anti-Cancer Drugs Revenue and Market Share by Player (2017-2022)
4.3 Global Lamea Oncology/Anti-Cancer Drugs Average Price by Player (2017-2022)
4.4 Global Lamea Oncology/Anti-Cancer Drugs Gross Margin by Player (2017-2022)
4.5 Lamea Oncology/Anti-Cancer Drugs Market Competitive Situation and Trends
4.5.1 Lamea Oncology/Anti-Cancer Drugs Market Concentration Rate
4.5.2 Lamea Oncology/Anti-Cancer Drugs Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion
5 Global Lamea Oncology/Anti-Cancer Drugs Sales, Revenue, Price Trend by Type
5.1 Global Lamea Oncology/Anti-Cancer Drugs Sales and Market Share by Type (2017-2022)
5.2 Global Lamea Oncology/Anti-Cancer Drugs Revenue and Market Share by Type (2017-2022)
5.3 Global Lamea Oncology/Anti-Cancer Drugs Price by Type (2017-2022)
5.4 Global Lamea Oncology/Anti-Cancer Drugs Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Lamea Oncology/Anti-Cancer Drugs Sales, Revenue and Growth Rate of Oral Therapy (2017-2022)
5.4.2 Global Lamea Oncology/Anti-Cancer Drugs Sales, Revenue and Growth Rate of Injectable Therapy (2017-2022)
6 Global Lamea Oncology/Anti-Cancer Drugs Market Analysis by Application
6.1 Global Lamea Oncology/Anti-Cancer Drugs Consumption and Market Share by Application (2017-2022)
6.2 Global Lamea Oncology/Anti-Cancer Drugs Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Lamea Oncology/Anti-Cancer Drugs Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Lamea Oncology/Anti-Cancer Drugs Consumption and Growth Rate of Chemotherapy (2017-2022)
6.3.2 Global Lamea Oncology/Anti-Cancer Drugs Consumption and Growth Rate of Targeted Therapy (2017-2022)
6.3.3 Global Lamea Oncology/Anti-Cancer Drugs Consumption and Growth Rate of Immunotherapy (Biologic Therapy) (2017-2022)
6.3.4 Global Lamea Oncology/Anti-Cancer Drugs Consumption and Growth Rate of Others (2017-2022)
7 Global Lamea Oncology/Anti-Cancer Drugs Sales and Revenue Region Wise (2017-2022)
7.1 Global Lamea Oncology/Anti-Cancer Drugs Sales and Market Share, Region Wise (2017-2022)
7.2 Global Lamea Oncology/Anti-Cancer Drugs Revenue and Market Share, Region Wise (2017-2022)
7.3 Global Lamea Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Lamea Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe Lamea Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China Lamea Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan Lamea Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India Lamea Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia Lamea Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America Lamea Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa Lamea Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
8 Global Lamea Oncology/Anti-Cancer Drugs Market Forecast (2022-2029)
8.1 Global Lamea Oncology/Anti-Cancer Drugs Sales, Revenue Forecast (2022-2029)
8.1.1 Global Lamea Oncology/Anti-Cancer Drugs Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global Lamea Oncology/Anti-Cancer Drugs Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global Lamea Oncology/Anti-Cancer Drugs Price and Trend Forecast (2022-2029)
8.2 Global Lamea Oncology/Anti-Cancer Drugs Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States Lamea Oncology/Anti-Cancer Drugs Sales and Revenue Forecast (2022-2029)
8.2.2 Europe Lamea Oncology/Anti-Cancer Drugs Sales and Revenue Forecast (2022-2029)
8.2.3 China Lamea Oncology/Anti-Cancer Drugs Sales and Revenue Forecast (2022-2029)
8.2.4 Japan Lamea Oncology/Anti-Cancer Drugs Sales and Revenue Forecast (2022-2029)
8.2.5 India Lamea Oncology/Anti-Cancer Drugs Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia Lamea Oncology/Anti-Cancer Drugs Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America Lamea Oncology/Anti-Cancer Drugs Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa Lamea Oncology/Anti-Cancer Drugs Sales and Revenue Forecast (2022-2029)
8.3 Global Lamea Oncology/Anti-Cancer Drugs Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global Lamea Oncology/Anti-Cancer Drugs Revenue and Growth Rate of Oral Therapy (2022-2029)
8.3.2 Global Lamea Oncology/Anti-Cancer Drugs Revenue and Growth Rate of Injectable Therapy (2022-2029)
8.4 Global Lamea Oncology/Anti-Cancer Drugs Consumption Forecast by Application (2022-2029)
8.4.1 Global Lamea Oncology/Anti-Cancer Drugs Consumption Value and Growth Rate of Chemotherapy (2022-2029)
8.4.2 Global Lamea Oncology/Anti-Cancer Drugs Consumption Value and Growth Rate of Targeted Therapy (2022-2029)
8.4.3 Global Lamea Oncology/Anti-Cancer Drugs Consumption Value and Growth Rate of Immunotherapy (Biologic Therapy) (2022-2029)
8.4.4 Global Lamea Oncology/Anti-Cancer Drugs Consumption Value and Growth Rate of Others (2022-2029)
8.5 Lamea Oncology/Anti-Cancer Drugs Market Forecast Under COVID-19
9 Industry Outlook
9.1 Lamea Oncology/Anti-Cancer Drugs Market Drivers Analysis
9.2 Lamea Oncology/Anti-Cancer Drugs Market Restraints and Challenges
9.3 Lamea Oncology/Anti-Cancer Drugs Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 Lamea Oncology/Anti-Cancer Drugs Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 Lamea Oncology/Anti-Cancer Drugs Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on Lamea Oncology/Anti-Cancer Drugs Industry Development
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Research Data Source
Global 5-Fluorouracil Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 76
The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030.
North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......
Global Carboplatin Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 79
The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......
Global Neutropenia Drugs Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 96
The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......
Global Small Molecule Cancer Drug Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......
Global Capecitabine Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 80
Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.
Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......
Global Oxaliplatin Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 104
Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely.
In this report, only The finished drug is covered, exclude API.
The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......
Global Cancer Treatment Drugs Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 158
According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period.
The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......
Global Capecitabine Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 93
According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period.
The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......
Global Methotrexate Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 95
According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period.
The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
